Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,567 |
|
|||||
| News | - | ||||||
| Day High | 21.00 | Low High |
|||||
| Day Low | 20.6001 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Synchronoss Technologies Inc | SNCRL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.15 | -0.71% | 20.85 | 16:00:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.00 | 20.6001 | 21.00 | 20.85 | 21.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 26 | 1,567 | $ 20.86 | $ 32,693 | - | 16.40 - 22.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 1 | $ 20.65 | USD |
Synchronoss Technologies Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 22.63M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Synchronoss Technologies News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SNCRL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.90 | 21.1999 | 20.50 | 21.02 | 3,342 | -0.05 | -0.24% |
| 1 Month | 21.00 | 21.28 | 17.55 | 20.90 | 5,814 | -0.15 | -0.71% |
| 3 Months | 19.95 | 22.60 | 17.55 | 21.00 | 6,372 | 0.90 | 4.51% |
| 6 Months | 17.00 | 22.60 | 16.7501 | 19.80 | 11,501 | 3.85 | 22.65% |
| 1 Year | 18.40 | 22.60 | 16.40 | 19.12 | 8,675 | 2.45 | 13.32% |
| 3 Years | 24.95 | 25.45 | 15.00 | 22.43 | 12,417 | -4.10 | -16.43% |
| 5 Years | 24.95 | 25.45 | 15.00 | 22.43 | 12,417 | -4.10 | -16.43% |
Synchronoss Technologies Description
| Synaptogenix, Inc. is a biopharmaceutical company. The Company is principally focused on developing therapeutics for patients with neurodegenerative diseases and developmental disorders. The Company is focused on developing a product platform based on a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer's disease (AD). Bryostatin-1 is a Protein Kinase C Epsilon (PKC e), a and e activator that was originally developed as a potential anticancer drug. The Company is evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease. |
